IRADIMED (NASDAQ: IRMD) reported Q2 EPS of $0.13, versus $0.07 reported last year. Revenue for the quarter came in at $4.7 million, versus $2.8 million reported last year.

For earnings history and earnings-related data on IRADIMED (IRMD) click here.